Barrington Research reiterated coverage on Anika Therapeutics with a new price target

11/1/24 10:25:08 AM ET

Medical/Dental Instruments

Health Care

Barrington Research reiterated coverage of Anika Therapeutics with a rating of Outperform and set a new price target of $25.00 from $37.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ANIK

Date	Price Target	Rating	Analyst
4/17/2025	$21.00	Buy	B. Riley Securities
11/1/2024	$37.00 → $25.00	Outperform	Barrington Research
8/14/2023	$24.00	Mkt Perform → Outperform	Barrington Research
3/7/2023		Outperform → Mkt Perform	Barrington Research
11/9/2022	$31.00	Mkt Perform → Outperform	Barrington Research
10/14/2022	$26.00	Equal-Weight	Stephens
3/9/2022		Outperform → Mkt Perform	Barrington Research
3/9/2022		Overweight → Equal-Weight	Stephens & Co.